Company intelligence / Profile preview
Tonghua Wantong Pharmaceutical
Tonghua, Jilin, Chinadnb.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Commercial
01
Overview
Tonghua Wantong Pharmaceutical develops and manufactures a broad range of pharmaceutical products with a strong focus on metabolic diseases such as diabetes. The company has multiple commercialized drugs in China—including insulins, oral antidiabetics, herbal medicines—and an active R&D pipeline targeting new small molecules and biologics. Several programs have reached approval status in China.
- Therapeutic areas
- OncologyEndocrinologyRheumatologyCardiovascularNeurology
- Modalities
- Small moleculeHerbal medicineBiologicPeptideCombination drug
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Tonghua Wantong Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tonghua Wantong Pharmaceutical.